Pregled bibliografske jedinice broj: 1171085
Styling without sheddin: novel topical formula reduces hair shedding by contracting the arrector pili muscle
Styling without sheddin: novel topical formula reduces hair shedding by contracting the arrector pili muscle // Dermatologic therapy, 31 (2018), 1; 121-122 doi:10.1111/dth.12575 (međunarodna recenzija, članak, stručni)
CROSBI ID: 1171085 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Styling without sheddin: novel topical formula
reduces hair shedding by contracting the arrector
pili muscle
Autori
McCoy John ; Goren Andy ; Kovacevic Maja ; Situm Mirna ; Stanimirovic Andrija ; Shapiro Jerry ; Sinclair Rodney
Izvornik
Dermatologic therapy (1396-0296) 31
(2018), 1;
121-122
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
arrector pilli ; ispadanje kose ; piloerekcija
(arrector pili ; hair shedding ; piloerection.)
Sažetak
Approximately 40% of women experience excessive hair shedding during styling (e.g., hair brushing). Previously, we demonstrated that topically applied phenylephrine, a potent α1 adrenergic receptor agonist, can be used to contract the arrector pili muscle of the follicular unit ; thus, increasing the force required to pluck hair and reducing shedding during brushing. While demonstrating efficacy, phenylephrine has several drawbacks when applied to the scalp, including the possibility cardiovascular events. We hypothesized that a high concentration of a weak α1 agonist would allow for: (a) rapid penetration through the stratum corneum eliciting a quick response ; (b) a low probability of cardiac adverse events owing to the low receptor binding affinity ; and (c) an efficacy of the weak α1 agonist similar to that of phenylephrine at the local site of application. Accordingly, we developed a novel topical solution, AB-102, containing a high concentration of a weak α1 agonist. Several studies were conducted to test the safety and efficacy of AB-102. In a dose escalating safety study, utilizing a wearable holter monitor, we observed no cardiac or hemodynamic adverse events. In addition, in a controlled efficacy study, AB-102 reduced the number of hairs shed during brushing by up to 77% (average of 38%).
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE